These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
566 related articles for article (PubMed ID: 18728151)
1. Novel human neutrophil agonistic properties of arsenic trioxide: involvement of p38 mitogen-activated protein kinase and/or c-jun NH2-terminal MAPK but not extracellular signal-regulated kinases-1/2. Binet F; Girard D J Leukoc Biol; 2008 Dec; 84(6):1613-22. PubMed ID: 18728151 [TBL] [Abstract][Full Text] [Related]
2. The effect of MAPK inhibitors on arsenic trioxide-treated Calu-6 lung cells in relation to cell death, ROS and GSH levels. Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH Anticancer Res; 2009 Oct; 29(10):3837-44. PubMed ID: 19846917 [TBL] [Abstract][Full Text] [Related]
3. Pharmacologic inhibitors of extracellular signal-regulated kinase (ERKs) and c-Jun NH(2)-terminal kinase (JNK) decrease glutathione content and sensitize human promonocytic leukemia cells to arsenic trioxide-induced apoptosis. Ramos AM; Fernandez C; Amrán D; Esteban D; de Blas E; Palacios MA; Aller P J Cell Physiol; 2006 Dec; 209(3):1006-15. PubMed ID: 16972261 [TBL] [Abstract][Full Text] [Related]
4. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer. Maeda H; Hori S; Nishitoh H; Ichijo H; Ogawa O; Kakehi Y; Kakizuka A Cancer Res; 2001 Jul; 61(14):5432-40. PubMed ID: 11454688 [TBL] [Abstract][Full Text] [Related]
5. ASK1 is activated by arsenic trioxide in leukemic cells through accumulation of reactive oxygen species and may play a negative role in induction of apoptosis. Yan W; Arai A; Aoki M; Ichijo H; Miura O Biochem Biophys Res Commun; 2007 Apr; 355(4):1038-44. PubMed ID: 17331470 [TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of arsenic trioxide on retinoblastoma: cell differentiation and apoptosis depending on arsenic trioxide concentration. Kim JH; Kim JH; Yu YS; Kim DH; Kim CJ; Kim KW Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1819-23. PubMed ID: 19060284 [TBL] [Abstract][Full Text] [Related]
7. Hydrogen peroxide-induced neuronal apoptosis is associated with inhibition of protein phosphatase 2A and 5, leading to activation of MAPK pathway. Chen L; Liu L; Yin J; Luo Y; Huang S Int J Biochem Cell Biol; 2009 Jun; 41(6):1284-95. PubMed ID: 19038359 [TBL] [Abstract][Full Text] [Related]
8. Curcumin stimulates reactive oxygen species production and potentiates apoptosis induction by the antitumor drugs arsenic trioxide and lonidamine in human myeloid leukemia cell lines. Sánchez Y; Simón GP; Calviño E; de Blas E; Aller P J Pharmacol Exp Ther; 2010 Oct; 335(1):114-23. PubMed ID: 20605902 [TBL] [Abstract][Full Text] [Related]
9. Role of the p38 mitogen-activated protein kinase pathway in the generation of arsenic trioxide-dependent cellular responses. Giafis N; Katsoulidis E; Sassano A; Tallman MS; Higgins LS; Nebreda AR; Davis RJ; Platanias LC Cancer Res; 2006 Jul; 66(13):6763-71. PubMed ID: 16818652 [TBL] [Abstract][Full Text] [Related]
10. p38 MAPK associated with stereoselective priming by grepafloxacin on O2- production in neutrophils. Niwa M; Hotta K; Kanamori Y; Kumada M; Hirota M; Kozawa O; Fujimoto S Free Radic Biol Med; 2004 May; 36(10):1259-69. PubMed ID: 15110391 [TBL] [Abstract][Full Text] [Related]
11. The role of p38 MAPK and JNK in Arsenic trioxide-induced mitochondrial cell death in human cervical cancer cells. Kang YH; Lee SJ J Cell Physiol; 2008 Oct; 217(1):23-33. PubMed ID: 18412143 [TBL] [Abstract][Full Text] [Related]
12. Modulation of arsenic trioxide-induced apoptosis by genistein and functionally related agents in U937 human leukaemia cells. Regulation by ROS and mitogen-activated protein kinases. Sánchez Y; Calle C; de Blas E; Aller P Chem Biol Interact; 2009 Nov; 182(1):37-44. PubMed ID: 19720055 [TBL] [Abstract][Full Text] [Related]
13. PTH regulation of c-Jun terminal kinase and p38 MAPK cascades in intestinal cells from young and aged rats. Buzzi N; Boland R; de Boland AR Biogerontology; 2007 Apr; 8(2):189-99. PubMed ID: 17120084 [TBL] [Abstract][Full Text] [Related]
14. Arsenic trioxide induces apoptosis through JNK and ERK in human mesothelioma cells. Eguchi R; Fujimori Y; Takeda H; Tabata C; Ohta T; Kuribayashi K; Fukuoka K; Nakano T J Cell Physiol; 2011 Mar; 226(3):762-8. PubMed ID: 20799280 [TBL] [Abstract][Full Text] [Related]
15. Activation of the p38 MAPK/Akt/ERK1/2 signal pathways is required for the protein stabilization of CDC6 and cyclin D1 in low-dose arsenite-induced cell proliferation. Liu Y; Hock JM; Sullivan C; Fang G; Cox AJ; Davis KT; Davis BH; Li X J Cell Biochem; 2010 Dec; 111(6):1546-55. PubMed ID: 20862710 [TBL] [Abstract][Full Text] [Related]
16. Novel indoloquinoline derivative, IQDMA, induces G(2)/M phase arrest and apoptosis in A549 cells through JNK/p38 MAPK signaling activation. Su JC; Lin KL; Chien CM; Lu CM; Chen YL; Chang LS; Lin SR Life Sci; 2009 Sep; 85(13-14):505-16. PubMed ID: 19699753 [TBL] [Abstract][Full Text] [Related]
17. Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways. Liu W; Liang Q; Balzar S; Wenzel S; Gorska M; Alam R J Allergy Clin Immunol; 2008 Apr; 121(4):893-902.e2. PubMed ID: 18395552 [TBL] [Abstract][Full Text] [Related]
18. Desipramine-induced Ca-independent apoptosis in Mg63 human osteosarcoma cells: dependence on P38 mitogen-activated protein kinase-regulated activation of caspase 3. Lu T; Huang CC; Lu YC; Lin KL; Liu SI; Wang BW; Chang PM; Chen IS; Chen SS; Tsai JY; Chou CT; Jan CR Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):297-303. PubMed ID: 18986328 [TBL] [Abstract][Full Text] [Related]
19. Bacterial phagocytosis activates extracellular signal-regulated kinase and p38 mitogen-activated protein kinase cascades in human neutrophils. McLeish KR; Klein JB; Coxon PY; Head KZ; Ward RA J Leukoc Biol; 1998 Dec; 64(6):835-44. PubMed ID: 9850168 [TBL] [Abstract][Full Text] [Related]
20. Mitogen-activated protein kinase expression and activation does not differentiate benign from malignant mesothelial cells. Vintman L; Nielsen S; Berner A; Reich R; Davidson B Cancer; 2005 Jun; 103(11):2427-33. PubMed ID: 15830375 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]